NCT06764537View on ClinicalTrials.gov

Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma

NANot yet recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Glioblastoma
Interventions
PROCEDURE

Blood collection

Blood collection (40 mL) in glioblastoma patients

Trial Locations (1)

54500

Cell Therapy Unit, Nancy Hospital, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT06764537 - Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma | Biotech Hunter | Biotech Hunter